Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study

Mariëlle M F Poels1, M Arfan Ikram, Aad van der Lugt

  • 1Department of Radiology, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

Stroke
|February 11, 2011
PubMed
Abstract

Insights

Cerebral microbleeds are common in older adults and rarely disappear over time. Their incidence is substantial, and risk factors vary by location, suggesting they may indicate disease progression.

Area of Science:

  • Neuroimaging
  • Geriatrics
  • Neurology

Background:

  • Cerebral microbleeds are prevalent in the elderly population.
  • The rate of microbleed occurrence with aging and their potential resolution over time remain unclear.

Purpose of the Study:

  • To determine the incidence rate of cerebral microbleeds in an aging general population.
  • To investigate whether previously identified microbleeds can resolve.
  • To identify determinants of incident microbleeds based on their location.

Main Methods:

  • The Rotterdam Scan Study included 831 participants (mean age 68.5 years).
  • Repeated brain MRI scans were performed with a mean follow-up interval of 3.4 years.
  • Multiple logistic regression analyses assessed determinants of incident microbleeds, considering their location.

Main Results:

  • Microbleed prevalence increased from 24.4% to 28.0% over the follow-up period.
  • Eighty-five participants (10.2%) developed new microbleeds; baseline microbleeds predicted new occurrences (OR, 5.38).
  • Microbleed resolution was rare (observed in only 6 individuals).
  • Cardiovascular risk factors, lacunar infarcts, and white matter lesion volume were associated with deep/infratentorial microbleeds.
  • Apolipoprotein E ε4/ε4 genotype and white matter lesion volume were linked to strictly lobar microbleeds.

Conclusions:

  • A substantial incidence of cerebral microbleeds occurs over a 3-year interval in the general population, with rare resolution.
  • Risk factors for incident microbleeds mirror those for prevalent ones and differ based on microbleed location.
  • T2-weighted MRI assessment of microbleeds may serve as a marker for cerebral amyloid angiopathy and hypertensive vasculopathy progression.